文献速递细菌感染、耐药与抗菌药物医院感染防控

交互式计算机决策支持对医院抗生素使用的影响(COMPASS):一项在瑞士三家医院开展的非盲整群随机试验

Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals.
PubMed 文献 · Lancet Infect Dis · 2022-07-20

COMPASS 试验在瑞士3家医院24个病房整群随机比较计算机化抗生素管理决策支持联合处方指标反馈与标准管理措施。意向性分析显示干预未显著减少总体抗生素使用(入院抗生素暴露 OR 1.12,95%CI 0.94-1.33);静脉转口服更常见(OR 1.9,95%CI 1.1-3.3),感染科会诊较少(OR 0.84,95%CI 0.59-1.25)。

要点

  • 干预未显著降低总体抗生素使用(OR 1.12,95%CI 0.94-1.33)。
  • 静脉转口服在干预组更常见(OR 1.9,95%CI 1.1-3.3)。
  • 作者认为使用不足、基线抗生素使用较低及首次使用延迟可能为影响因素。

核心结论

  • 作者结论:整合多模式计算机化抗生素管理干预未显著减少总体抗生素使用这一主要结局;可能的影响因素为使用不足、基线抗生素使用相对较低以及病房入院至首次使用CDSS之间的延迟。

研究设计与样本

  • COMPASS 为多中心、整群随机、平行组、非盲优效性试验,旨在评估多模式计算机化抗生素管理干预能否减少成人住院患者的抗生素使用。
  • 配对匹配后,瑞士3家三级与二级医院的24个病房按1:1随机分配至CDSS干预或标准抗生素管理措施,使用在线随机序列生成器。
  • 多模式干预包括CDSS提供抗菌治疗选择、疗程和再评估支持,以及抗菌处方质量反馈。
  • 主要结局为以每例入院治疗天数测量的总体全身抗生素使用,采用校正的跨栏负二项混合效应模型分析,并按意向性治疗和符合方案分析。
  • 研究注册于ClinicalTrials.gov(标识NCT03120975)。

主要发现

  • 2018年10月1日至2019年12月31日随机分配24个集群(日内瓦大学医院16个、提契诺州立医院8个);干预组11384例入院中4578例(40.2%)接受抗生素治疗,对照组9673例中4142例(42.8%)。
  • 未校正总体每例入院平均治疗天数干预组略低于对照组(3.2天,SD 6.2 vs 3.5天,SD 6.8;p<0.0001),接受抗生素患者中两组相似(7.9天,SD 7.6 vs 8.1天,SD 8.4;p=0.50)。
  • 校正混杂因素后,两组入院接受抗生素的比值无统计学显著差异(干预vs对照 OR 1.12,95%CI 0.94-1.33);有抗生素暴露的入院中治疗天数也相似(发生率比0.98,95%CI 0.90-1.07)。
  • CDSS在3466/4578例(75.7%)任何抗生素处方入院中至少使用一次,但日内瓦仅1602/2721例(58.9%)从抗生素治疗第一天起使用;未从第一天使用者平均使用CDSS时间为8.9天。
  • 基于1195份随机抽取病历的人工审核,校正混杂因素后干预组静脉转口服显著更频繁(154/201[76.6%] vs 187/215[87%],+10.4%;OR 1.9,95%CI 1.1-3.3);感染科专家会诊干预组较少(388/2889[13.4%] vs 405/2390[16.9%];OR 0.84,95%CI 0.59-1.25)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出可能的影响因素为使用不足、基线抗生素使用相对较低以及病房入院至首次使用CDSS之间的延迟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Computerised decision-support systems (CDSSs) for antibiotic stewardship could help to assist physicians in the appropriate prescribing of antibiotics. However, high-quality evidence for their effect on the quantity and quality of antibiotic use remains scarce. The aim of our study was to assess whether a computerised decision support for antimicrobial stewardship combined with feedback on prescribing indicators can reduce antimicrobial prescriptions for adults admitted to hospital. METHODS: The Computerised Antibiotic Stewardship Study (COMPASS) was a multicentre, cluster-randomised, parallel-group, open-label superiority trial that aimed to assess whether a multimodal computerised antibiotic-stewardship intervention is effective in reducing antibiotic use for adults admitted to hospital. After pairwise matching, 24 wards in three Swiss tertiary-care and secondary-care hospitals were randomised (1:1) to the CDSS intervention or to standard antibiotic stewardship measures using an online random sequence generator. The multimodal intervention consisted of a CDSS providing support for choice, duration, and re-evaluation of antimicrobial therapy, and feedback on antimicrobial prescribing quality. The primary outcome was overall systemic antibiotic use measured in days of therapy per admission, using adjusted-hurdle negative-binomial mixed-effects models. The analysis was done by intention to treat and per protocol. The study was registered with ClinicalTrials.gov (identifier NCT03120975). FINDINGS: 24 clusters (16 at Geneva University Hospitals and eight at Ticino Regional Hospitals) were eligible and randomly assigned to control or intervention between Oct 1, 2018, and Dec 31, 2019. Overall, 4578 (40·2%) of 11 384 admissions received antibiotic therapy in the intervention group and 4142 (42·8%) of 9673 in the control group. The unadjusted overall mean days of therapy per admission was slightly lower in the intervention group than in the control group (3·2 days of therapy per admission, SD 6·2, vs 3·5 days of therapy per admission, SD 6·8; p<0·0001), and was similar among patients receiving antibiotics (7·9 days of therapy per admission, SD 7·6, vs 8·1 days of therapy per admission, SD 8·4; p=0·50). After adjusting for confounders, there was no statistically significant difference between groups for the odds of an admission receiving antibiotics (odds ratio [OR] for intervention vs control 1·12, 95% CI 0·94-1·33). For admissions with antibiotic exposure, days of therapy per admission were also similar (incidence rate ratio 0·98, 95% CI 0·90-1·07). Overall, the CDSS was used at least once in 3466 (75·7%) of 4578 admissions with any antibiotic prescription, but from the first day of antibiotic treatment for only 1602 (58·9%) of 2721 admissions in Geneva. For those for whom the CDSS was not used from the first day, mean time to use of CDSS was 8·9 days. Based on the manual review of 1195 randomly selected charts, transition from intravenous to oral therapy was significantly more frequent in the intervention group after adjusting for confounders (154 [76·6%] of 201 vs 187 [87%] of 215, +10·4%; OR 1·9, 95% CI 1·1-3·3). Consultations by infectious disease specialists were less frequent in the intervention group (388 [13·4%] of 2889) versus the control group (405 [16·9%] of 2390; OR 0·84, 95% CI 0·59-1·25). INTERPRETATION: An integrated multimodal computerised antibiotic stewardship intervention did not significantly reduce overall antibiotic use, the primary outcome of the study. Contributing factors were probably insufficient uptake, a setting with relatively low antibiotic use at baseline, and delays between ward admission and first CDSS use. FUNDING: Swiss National Science Foundation. TRANSLATIONS: For the French and Italian translations of the abstract see Supplementary Materials section.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Catho G, Sauser J, Coray V, et al. Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals. Lancet Infect Dis. 2022. PMID: 35870478. doi:10.1016/S1473-3099(22)00308-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。